[转移性黑色素瘤治疗的新希望？] - Suppr

Suppr

超能文献

[New hope in metastatic melanoma treatment?].

作者信息

Guillot B

机构信息

Département de dermatologie, hôpital Saint-Éloi, CHU de Montpellier, 34295 Montpellier cedex 5, France.

出版信息

Ann Dermatol Venereol. 2012 Oct;139(10):693-4. doi: 10.1016/j.annder.2012.05.030. Epub 2012 Sep 8.

DOI:10.1016/j.annder.2012.05.030

PMID:23122388

Abstract

摘要

相似文献

[New hope in metastatic melanoma treatment?].

Ann Dermatol Venereol. 2012 Oct;139(10):693-4. doi: 10.1016/j.annder.2012.05.030. Epub 2012 Sep 8.

[Metastatic melanoma: some hope from ipilimumab and vemurafenib].

Rev Med Liege. 2012 Feb;67(2):64-8.

[New treatment options for metastatic melanoma].

Dtsch Med Wochenschr. 2014 Jul;139(28-29):1462-7. doi: 10.1055/s-0034-1370155. Epub 2014 Jul 1.

[Unblocking antitumor immune response: novel possibilities for the immunotherapy of melanoma].

Magy Onkol. 2013 Jun;57(2):100-7. Epub 2013 Apr 28.

[Treatment of metastatic melanoma: are we entering the era of targeted treatment?].

Praxis (Bern 1994). 2012 Oct 31;101(22):1423-9. doi: 10.1024/1661-8157/a001030.

Beyond ipilimumab: new approaches target the immunological synapse.

J Natl Cancer Inst. 2011 Jul 20;103(14):1079-82. doi: 10.1093/jnci/djr281. Epub 2011 Jul 7.

Strides in melanoma announced: maximizing value comes next.

J Natl Cancer Inst. 2011 Jul 6;103(13):997-9. doi: 10.1093/jnci/djr254. Epub 2011 Jun 21.

[Malignant melanoma].

Dtsch Med Wochenschr. 2012 Dec;137(49):2548-50. doi: 10.1055/s-0032-1327270. Epub 2012 Nov 27.

Discontinuation of melanoma combination immunotherapy.

Lancet Oncol. 2017 Oct;18(10):e565. doi: 10.1016/S1470-2045(17)30668-X. Epub 2017 Sep 1.

Long-term survival of a patient with metastatic melanoma treated with nivolumab and vemurafenib, with the development of vitiligo.

Eur J Dermatol. 2017 Apr 1;27(2):177-178. doi: 10.1684/ejd.2016.2925.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

[New hope in metastatic melanoma treatment?].

Ann Dermatol Venereol. 2012 Oct;139(10):693-4. doi: 10.1016/j.annder.2012.05.030. Epub 2012 Sep 8.

[Metastatic melanoma: some hope from ipilimumab and vemurafenib].

Rev Med Liege. 2012 Feb;67(2):64-8.

[New treatment options for metastatic melanoma].

Dtsch Med Wochenschr. 2014 Jul;139(28-29):1462-7. doi: 10.1055/s-0034-1370155. Epub 2014 Jul 1.

[Unblocking antitumor immune response: novel possibilities for the immunotherapy of melanoma].

Magy Onkol. 2013 Jun;57(2):100-7. Epub 2013 Apr 28.

[Treatment of metastatic melanoma: are we entering the era of targeted treatment?].

Praxis (Bern 1994). 2012 Oct 31;101(22):1423-9. doi: 10.1024/1661-8157/a001030.

Beyond ipilimumab: new approaches target the immunological synapse.

J Natl Cancer Inst. 2011 Jul 20;103(14):1079-82. doi: 10.1093/jnci/djr281. Epub 2011 Jul 7.

Strides in melanoma announced: maximizing value comes next.

J Natl Cancer Inst. 2011 Jul 6;103(13):997-9. doi: 10.1093/jnci/djr254. Epub 2011 Jun 21.

[Malignant melanoma].

Dtsch Med Wochenschr. 2012 Dec;137(49):2548-50. doi: 10.1055/s-0032-1327270. Epub 2012 Nov 27.

Discontinuation of melanoma combination immunotherapy.

Lancet Oncol. 2017 Oct;18(10):e565. doi: 10.1016/S1470-2045(17)30668-X. Epub 2017 Sep 1.

Long-term survival of a patient with metastatic melanoma treated with nivolumab and vemurafenib, with the development of vitiligo.

Eur J Dermatol. 2017 Apr 1;27(2):177-178. doi: 10.1684/ejd.2016.2925.